Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bayer Aktienges Ads (BAYRY)

Bayer Aktienges Ads (BAYRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 58,750,716
  • Shares Outstanding, K 3,730,204
  • Annual Sales, $ 48,230 M
  • Annual Income, $ 4,531 M
  • 60-Month Beta 1.18
  • Price/Sales 1.19
  • Price/Cash Flow 4.42
  • Price/Book 1.08
  • Price/Earnings ttm 8.26
  • Earnings Per Share ttm 1.86
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 04/23/20
  • Annual Dividend & Yield 0.55 (3.47%)
  • Most Recent Dividend 0.546 on 04/29/19
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.54
  • Number of Estimates 1
  • High Estimate 0.54
  • Low Estimate 0.54
  • Prior Year 0.72
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.5500 +25.50%
on 03/16/20
16.7000 -5.69%
on 03/10/20
-0.7500 (-4.55%)
since 03/09/20
3-Month
12.5500 +25.50%
on 03/16/20
21.5900 -27.05%
on 01/23/20
-5.0800 (-24.39%)
since 01/09/20
52-Week
12.5500 +25.50%
on 03/16/20
21.5900 -27.05%
on 01/23/20
-1.3200 (-7.73%)
since 04/09/19

Most Recent Stories

More News
Acute Otitis Media Treatment Market Insights By Size, Share, Future Growth And Forecast From 2019-2029

The research study on Global Acute Otitis Media Treatment market 2019 presents an extensive analysis of current Acute Otitis Media Treatment market size, drivers, trends, opportunities, challenges, as...

ABT : 86.04 (+1.28%)
BAYRY : 15.7500 (+2.54%)
LLY : 145.73 (-0.34%)
GSK : 38.88 (+2.10%)
NVS : 84.85 (-0.90%)
PDP.VN : 0.300 (+1.69%)
Topical Drug Delivery System Market Growth, Size, Share, Trends, Status and Forecast 2020-2027

A new research report titled “” successfully exhibits the complete scenario of the global and an individual analysis of the various regional segments.

BAYRY : 15.7500 (+2.54%)
CRRTF : 0.3766 (+12.02%)
NVS : 84.85 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Global Constipation Treatment Drug Market 2019 Industry Segmentation, CAGR Status, Leading Trends, and Forecast To 2025

The report provides rational insights along with historical and forecast data to said in better understanding of the Global Constipation Treatment Drug Market. The report provides a comprehensive analysis...

ABT : 86.04 (+1.28%)
ALBO : 17.11 (+4.33%)
BAYRY : 15.7500 (+2.54%)
IRWD : 9.75 (-0.91%)
PBH : 40.43 (+0.40%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
The Zacks Analyst Blog Highlights: Amazon, Medtronic, Vertex Pharmaceuticals, Intuit and Bayer

The Zacks Analyst Blog Highlights: Amazon, Medtronic, Vertex Pharmaceuticals, Intuit and Bayer

MDT : 101.03 (+1.76%)
AMZN : 2,042.76 (-0.01%)
INTU : 252.10 (+2.51%)
VRTX : 246.61 (-1.22%)
BAYRY : 15.7500 (+2.54%)
Global Anti-Inflammatory Therapeutics Market (2020 to 2024) - Players Featured Include AstraZeneca, Bayer AG & F. Hoffmann-La Roche Among Others - ResearchAndMarkets.com

The "Global Anti-Inflammatory Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

BAYRY : 15.7500 (+2.54%)
Global Acute Otitis Media Treatment Market 2020 - Industry Scenario, Strategies, Growth Factors and Forecast to 2025

has added a new informative report titled as, to its storehouse which analyzes the market pricing trends, consumption trends and forecast sales between 2020 and 2025. The report examines the present status...

ABT : 86.04 (+1.28%)
BAYRY : 15.7500 (+2.54%)
LLY : 145.73 (-0.34%)
GSK : 38.88 (+2.10%)
NVS : 84.85 (-0.90%)
PDP.VN : 0.300 (+1.69%)
Top Research Reports for Amazon, Medtronic & Vertex

Top Research Reports for Amazon, Medtronic & Vertex

VRTX : 246.61 (-1.22%)
MDT : 101.03 (+1.76%)
INTU : 252.10 (+2.51%)
FE : 44.75 (+3.52%)
BAYRY : 15.7500 (+2.54%)
AMZN : 2,042.76 (-0.01%)
Diabetic Macular Edema Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies

The global diabetic macular edema (DME) market is projected to register a sluggish expansion at 1.1% CAGR through 2027, according to a report by Future Market Insights (FMI). The report estimates the market...

ALIM : 4.01 (-0.99%)
AGN : 182.20 (+0.62%)
BAYRY : 15.7500 (+2.54%)
VRX.TO : 30.80 (-3.33%)
Novartis Terminates Sale of Sandoz Dermatology Business

Novartis (NVS) terminates sale of Sandoz US generic oral solids and dermatology businesses to Aurobindo Pharma USA Inc.

TEVA : 10.16 (+3.25%)
MYL : 16.08 (+6.21%)
NVS : 84.85 (-0.90%)
BAYRY : 15.7500 (+2.54%)
Acute Otitis Media Treatment Market Insights By Size, Share, Future Growth And Forecast From 2019-2029

The research study on Global Acute Otitis Media Treatment market 2019 presents an extensive analysis of current Acute Otitis Media Treatment market size, drivers, trends, opportunities, challenges, as...

ABT : 86.04 (+1.28%)
BAYRY : 15.7500 (+2.54%)
LLY : 145.73 (-0.34%)
GSK : 38.88 (+2.10%)
NVS : 84.85 (-0.90%)
PDP.VN : 0.300 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade BAYRY with:

Key Turning Points

2nd Resistance Point 15.9767
1st Resistance Point 15.8633
Last Price 15.7500
1st Support Level 15.5933
2nd Support Level 15.4367

See More

52-Week High 21.5900
Fibonacci 61.8% 18.1367
Fibonacci 50% 17.0700
Fibonacci 38.2% 16.0033
Last Price 15.7500
52-Week Low 12.5500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar